Study Details
PHINDER: A study to find ways to detect Pulmonary Hypertension earlier in patients with Interstitial Lung Disease
(IRB#: IRB_00169643)
Having interstitial lung disease (ILD) puts a person at a higher risk for a condition called pulmonary hypertension (PH). Pulmonary hypertension is high blood pressure in the blood vessels that supply the lungs, which in turn can put a strain on the heart. The study will evaluate the best tests to screen for pulmonary hypertension in patients with interstitial lung disease. The study wants to see the most effective screening tests, promote awareness, and encourage screening. Being in the study requires up to 28 days with several visits to the study clinic. Medical tests will be done during the study to track the health of participants.
- All genders
- Over 18 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 18 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- 18 years and older
- Diagnosis of interstitial lung disease (ILD)
- Ability to attend in person visits at a study clinic
Exclusion Criteria
- Currently on an FDA-approved pulmonary arterial hypertension medication
- Diagnosed with chronic obstructive pulmonary disease (COPD) (airflow is blocked and it is difficult to breathe)
- Uncontrolled or untreated sleep apnea (breathing stops and starts repeatedly when sleeping)
- Pulmonary embolism (one or more arteries become blocked by a blood clot) within the past 3 months
Will I be paid for my time?
Yes
IRB#: IRB_00169643
PI: Emily Beck
Department: PULMONARY
Approval Date: 2024-04-17 06:00:00
Specialties: Cardiology, Pulmonary